Quintrio
Home

PHARMACEUTICAL PREPARATIONS

Valion Bio, Inc. Common Stock

VBIO

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Last trade $0.5651
Day change +$0.0361 (+6.82%)
Day range $0.507 – $0.597
Volume 1,106,479
Market cap $1M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$1.11M
Price / earnings
—
Price / book
0.26×
Price / sales
7.61×
EV / sales
43.77×
EV / EBITDA
-0.45×

Profitability

Earnings per share
-$7.82
Return on assets
-50.45%
Return on equity
-385.82%
Dividend yield
0%

Liquidity and leverage

Debt / equity
1.74×
Current ratio
1.13×
Quick ratio
0.88×
Cash ratio
0.7×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$14.67M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for VBIO, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026
Revenue$0
Cost of revenue$0
Gross profit$0
Selling, general and administrative$3.72M
Research and development$2.7M
Total operating expenses$6.42M
Operating income-$6.42M
Interest expense-$691K
Income before taxes-$7.06M
Income taxes$0
Net income-$7.1M
Net income attributable to common shareholders-$7.35M
EBITDA-$6.51M
Basic earnings per share-$54.25
Diluted earnings per share-$54.25

Recent news

Company coverage with links to the original publishers.

Publication times in UTC

No recent company news found.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Aug 31, 20261-for-25reverse split